Intragastric Balloon Market  Analysis Report 2025: Market to Grow by a CAGR of 13.9 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Key Insights

The Intragastric Balloon Market size was valued at USD 39.2 USD Million in 2023 and is projected to reach USD 97.49 USD Million by 2032, exhibiting a CAGR of 13.9 % during the forecast period. The Intragastric Balloon (IGB) stands for non-surgical weight loss object which is done endoscopically inside the stomach. It is produced in many varieties that contain saline fluids and gas balloons. The balloon takes some room in the stomach. The client does not feel the hunger and will eat less food than before. It is normally used in combo with diet plus lifestyle changes for patients whose BMIs are higher and did not respond to those other weight loss methods. The market of IGBs has registered steady rates of expansion due to increasing obesity prevalence and demand for a minimally invasive weight-reduction methodology. On the other hand, it could be impacted by a variety of factors such as the implication of regulatory changes, market competition, and availability of alternative treatments.

Intragastric Balloon Trends

• Increasing demand for minimally invasive weight loss procedures
• Growing adoption of gastric balloons for short-term weight management
• Technological advancements in balloon designs and filling materials

Driving Forces: What's Propelling the Intragastric Balloon Market

• Rising Prevalence of Obesity and Related Comorbidities: The escalating global obesity epidemic is a primary driver, fueling demand for effective and minimally invasive weight loss solutions. Intragastric balloons offer a compelling alternative for individuals seeking weight management assistance.
• Technological Advancements and Enhanced Safety: Continuous innovation leads to safer and more effective balloon designs, improved placement techniques, and reduced complication rates. These advancements increase patient acceptance and physician confidence in recommending the procedure.
• Favorable Reimbursement Landscape and Expanded Access: Positive shifts in insurance coverage and reimbursement policies are broadening access to intragastric balloon procedures, making them more financially viable for a larger patient population. This includes a growing number of centers offering the procedure.
• Growing Awareness and Patient Acceptance: Increased public awareness campaigns and successful patient testimonials are fostering positive perceptions of intragastric balloons as a viable weight loss option. This increased awareness translates into higher demand.
• Expansion into Emerging Markets: The market is witnessing significant growth opportunities in developing economies with rising obesity rates and increased healthcare spending.

Challenges and Restraints in the Intragastric Balloon Market

• Potential complications associated with balloon placement and removal
• Limited long-term data on the efficacy and safety of intragastric balloons
• High upfront costs of procedures and insurance coverage concerns
• Competition from alternative weight loss methods and medications

Emerging Trends in Intragastric Balloon

• Development of adjustable and dissolvable gastric balloons
• Integration of AI and virtual reality for patient monitoring and support
• Personalized treatment plans tailored to individual patient needs

Growth Catalysts in the Intragastric Balloon Industry

• Increasing investment in research and development by market players
• Strategic partnerships between manufacturers and healthcare providers
• Focus on patient education and awareness programs
• Expansion of intragastric balloon procedures into emerging markets

Market Segmentation: Intragastric Balloon Analysis

Product Type:

• Single Balloon
• Dual Balloon
• Triple Balloon

Administration:

• Pill
• Endoscopy

Filling Material:

• Saline-Filled
• Gas-Filled

End-user:

• Hospitals & Clinics
• Outpatient Surgical Centers
• Others

Leading Players in the Intragastric Balloon Market

• Allurion Technologies, Inc.
• Apollo Endosurgery Inc.
• ReShape Lifesciences, Inc.
• Spatz Medical
• Lexel SRL
• Medispar NV
• Endalis
• Districlass Medical
• Silimed Brazil
• Suzhou Shenyun Medical Equipment Co., Ltd

Significant Developments in the Intragastric Balloon Sector

• October 2023: Allurion completed patient enrollment in its AUDACITY trial, a pivotal trial for U.S. FDA approval.
• September 2023: ReShape Lifesciences entered into a license agreement with Biorad to distribute Obalon balloons in Asia Pacific.
• June 2023: Allurion and Medtronic collaborated to expand the Allurion weight loss program in CEMA.
• April 2020: Allurion submitted a PMA application to the U.S. FDA for its Elipse gastric balloon.
• May 2019: Spatz Medical announced positive clinical trial results for its adjustable gastric balloon.

Comprehensive Coverage Intragastric Balloon Market Report

The comprehensive Intragastric Balloon Market Report provides in-depth insights and data-driven analysis to understand the current state and future trajectory of this dynamic market. Our report offers a holistic view, encompassing key market segments and competitive dynamics, empowering stakeholders to make informed decisions.

• Market Size, Growth, and Forecast:
  • Historical market size and revenue (2017-2021)
  • Current market valuation (2022)
  • Detailed forecast of market size and revenue (2023-2030), segmented by key parameters
  • Analysis of growth rates and underlying trends influencing market expansion.
• Segment-Specific Analysis: A granular examination of market segments to identify high-growth areas and opportunities.
  • Product Type: Comprehensive analysis of single-balloon and double-balloon systems, including their respective market shares and growth prospects.
  • Procedure Type: Detailed breakdown of the market based on endoscopic and surgical placement techniques, along with their associated advantages and disadvantages.
  • End-User Analysis: Market segmentation by end-users including hospitals, clinics, weight-loss centers, and ambulatory surgical centers. Analysis includes market share and growth potential for each.
  • Regional Analysis: In-depth exploration of regional markets (North America, Europe, Asia-Pacific, and Rest of the World), identifying key regional drivers and growth opportunities.
  • Key Drivers, Restraints, and Opportunities: Identification of key factors influencing market growth, including regulatory hurdles and future potential.
• Competitive Landscape and Company Profiles: Detailed profiles of key players in the intragastric balloon market, providing a clear understanding of the competitive dynamics.
  • Company Overviews: In-depth profiles of leading companies, highlighting their market presence, strategies, and financial performance.
  • Product Portfolios: Analysis of product offerings, including features, specifications, and competitive advantages.
  • Market Share Analysis: Comprehensive assessment of market share held by key players.
  • Competitive Strategies and Future Outlook: Insight into the competitive strategies employed by leading companies and their projected market performance.
  • Mergers & Acquisitions Analysis: Examination of recent and potential mergers and acquisitions impacting the market landscape.
• Industry Insights and Future Outlook: Forward-looking analysis of the intragastric balloon market, providing valuable insights for strategic planning.
  • Technological Advancements: Discussion of emerging technologies and their impact on the market.
  • Regulatory Landscape: Assessment of the regulatory environment and its influence on market growth.
  • Future Market Trends: Predictions of key trends shaping the future of the intragastric balloon market.
  • Expert Opinions: Inclusion of insights from industry experts and thought leaders.

Regional Insight

The global intragastric balloon market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to hold the largest market share due to high obesity rates and well-developed healthcare infrastructure.

DROCs

• Drivers: Obesity prevalence, minimally invasive procedures
• Restraints: Complications, high upfront costs
• Opportunities: Technological advancements, personalized treatment plans
• Challenges: Competition from alternative weight loss methods

Pricing Analysis

The price of an intragastric balloon procedure can vary depending on the product type, administration method, and geographic location. The average price for a single balloon procedure in the U.S. ranges from USD 6,000 to USD 10,000.

Import And Export Analysis

The global intragastric balloon market is characterized by significant trade activity. Major import and export regions include the United States, China, and the European Union.

Patent/Trademark Analysis

The intragastric balloon market is protected by numerous patents and trademarks held by various manufacturers. These include patents on balloon design, materials, and filling materials, as well as trademarks for brand names.